In
Parkinson's disease,
dopamine depletion leads to hyperactivity of
cholinergic interneurons in the caudate-putamen (CPu).
Botulinum neurotoxin-A (
BoNT-A) inhibits the release of
acetylcholine in the peripheral nervous system and is also thought to act as a local
anticholinergic drug when injected intrastriatally. In hemiparkinsonian (hemi-PD) rats, a unilateral intrastriatal injection of 1 ng
BoNT-A significantly diminished
apomorphine-induced rotation behavior for at least 3 months, the effect fading thereafter. A second intrastriatal
BoNT-A application, 6 months after the first one, led to a stronger and longer-lasting, beneficial behavioral reaction. As a single
BoNT-A injection was not cytotoxic in the rat striatum and resembled
BoNT-A treatment in clinical practice, here, we investigated the structural outcome of repeated intrastriatal
BoNT-A injections with respect to striatal volume, the number of
choline acetyltransferase-immunoreactive (ChAT-ir) interneurons and of the length of their dendritic arbors, and the numeric density of ChAT-ir
BoNT-A-induced varicosities (BiVs). Repeated unilateral intrastriatal
BoNT-A application decreased the volume of the injected CPu, but did not significantly change the number of striatal ChAT-ir interneurons. Also, the total dendrite length of ChAT-ir interneurons after repeated
BoNT-A application resembled the values in double vehicle-injected hemi-PD rats. In repeatedly
BoNT-A-injected hemi-PD rats, the numeric density of ChAT-ir BiVs in the CPu was increased compared with rats only intrastriatally injected once with
BoNT-A. Even repeated
BoNT-A injections in rat striata did not cause substantial morphological changes in ChAT-ir neuron, except for the increased numeric density of ChAT-ir BiVs.